|
|
|
|
|
|
|
|
 |
|
| Author |
Message |
|
|
 |
Thu Dec 17, 2015 1:16 pm  |
I guess I have very low expectation of eye creams. I have never seen any eye cream having a dramatic improvement effect over my eyes.
Most time, I am satisfied if I do not have allergy to the eye cream and it can moisturize the skin around my eye areas.
By the way, for very dry skins, I do not think Valmont eye factor II alone can effectively moisturize eye areas.
I do NOT see any effect, such as reducing dark circles and lines, of factor II over my eyes.
Factor III may be more effective moisturizing eye areas and slightly better in reducing dry lines under eyes.
Still, there is no magic from these eye creams, though they are truly expensive. |
|
|
|
|
|
Sat Feb 13, 2016 3:10 pm |
Comparison between Valmont eye factor II and Cellcosmet eye cream
I want to talk about the advantage of Cellcosmet eye cream over Valmont factor II.
If you do not have allergy to Cellcosmet eye cream, I would recommend it over valmont eye factor II for three reasons. First, it is easier to extent Cellcosmet eye cream around eye areas. Second, it is more moisturizing than valmont eye factor II. It is getting cold nowadays. Eye factor II feels very dry during cold winter. I need to apply a thick layer around my eye areas. After a while, some white scrapings would be around my eye areas. I guess this because it is not easy for the skin to absorb factor II. Third, Cellcosmet eye cream is much cheaper. |
|
|
|
|
| Mon Dec 23, 2024 1:01 am |
If this is your first visit to the EDS Forums please take the time to register. Registration is required for you to post on the forums. Registration will also give you the ability to track messages of interest, send private messages to other users, participate in Gift Certificates draws and enjoy automatic discounts for shopping at our online store. Registration is free and takes just a few seconds to complete.
Click Here to join our community.
If you are already a registered member on the forums, please login to gain full access to the site. |
|
 |
|
|
|
